HRP950524B1 - Quinoxaline, process for its preparation and the use thereof - Google Patents

Quinoxaline, process for its preparation and the use thereof

Info

Publication number
HRP950524B1
HRP950524B1 HR950524A HRP950524A HRP950524B1 HR P950524 B1 HRP950524 B1 HR P950524B1 HR 950524 A HR950524 A HR 950524A HR P950524 A HRP950524 A HR P950524A HR P950524 B1 HRP950524 B1 HR P950524B1
Authority
HR
Croatia
Prior art keywords
quinoxaline
alkoxy
preparation
formula
carbonyl
Prior art date
Application number
HR950524A
Other languages
English (en)
Inventor
Manfred Roesner
Uta-Maria Billhardt-Troughton
Reinhard Kirsch
Joerg-Peter Kleim
Cristoph Meichsner
Guenther Riess
Irvin Winkler
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of HRP950524A2 publication Critical patent/HRP950524A2/hr
Publication of HRP950524B1 publication Critical patent/HRP950524B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR950524A 1994-10-19 1995-10-18 Quinoxaline, process for its preparation and the use thereof HRP950524B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437406A DE4437406A1 (de) 1994-10-19 1994-10-19 Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (2)

Publication Number Publication Date
HRP950524A2 HRP950524A2 (en) 1997-10-31
HRP950524B1 true HRP950524B1 (en) 2002-06-30

Family

ID=6531202

Family Applications (1)

Application Number Title Priority Date Filing Date
HR950524A HRP950524B1 (en) 1994-10-19 1995-10-18 Quinoxaline, process for its preparation and the use thereof

Country Status (27)

Country Link
US (1) US5723461A (pl)
EP (1) EP0708093B1 (pl)
JP (1) JPH08225544A (pl)
KR (1) KR960014108A (pl)
CN (1) CN1094930C (pl)
AT (1) ATE198747T1 (pl)
AU (1) AU708293B2 (pl)
BR (1) BR9504456A (pl)
CA (1) CA2160859A1 (pl)
CZ (1) CZ271295A3 (pl)
DE (2) DE4437406A1 (pl)
DK (1) DK0708093T3 (pl)
ES (1) ES2154311T3 (pl)
FI (1) FI954946A7 (pl)
GR (1) GR3035673T3 (pl)
HR (1) HRP950524B1 (pl)
HU (1) HUT73485A (pl)
IL (1) IL115641A0 (pl)
MY (1) MY132057A (pl)
NO (1) NO306615B1 (pl)
NZ (1) NZ280258A (pl)
PL (1) PL184860B1 (pl)
PT (1) PT708093E (pl)
SI (1) SI9500329A (pl)
SK (1) SK128495A3 (pl)
TW (1) TW328954B (pl)
ZA (1) ZA958783B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369057B1 (en) * 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
WO1999025327A2 (en) * 1997-11-14 1999-05-27 Warner-Lambert Company Small molecule intervention in hiv-1 replication
GB9901795D0 (en) * 1999-01-28 1999-03-17 Glaxo Group Ltd Chemical compounds
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
WO2002087500A2 (en) * 2001-04-27 2002-11-07 Newbiotics, Inc. Viral enzyme activated prototoxophores and use of same to treat viral infections
WO2005018531A2 (en) * 2003-08-26 2005-03-03 'chemical Diversity Research Institute', Ltd. Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
US7351709B2 (en) * 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
MX371331B (es) 2012-04-24 2020-01-27 Vertex Pharma Inhibidores de la proteina cinasa dependiente de acido desoxirribonucleico(adn-pk).
ME03336B (me) 2013-03-12 2019-10-20 Vertex Pharma Inhibitori dnk-pk
JP6408569B2 (ja) 2013-10-17 2018-10-17 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ Ｄｎａ−ｐｋ阻害剤としての（ｓ）−ｎ−メチル−８−（１−（（２’−メチル−［４，５’−ビピリミジン］−６−イル）アミノ）プロパン−２−イル）キノリン−４−カルボキサミドおよびその重水素化誘導体の共結晶
EP3518931A4 (en) 2016-09-27 2020-05-13 Vertex Pharmaceuticals Incorporated METHOD FOR TREATING CANCER WITH A COMBINATION OF DNA-DAMAGING SUBSTANCES AND DNA-PK INHIBITORS
AU2022303386A1 (en) * 2021-07-02 2023-12-14 Aldeyra Therapeutics, Inc. Heterocyclic aldehyde trapping compounds and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE205837T1 (de) * 1991-04-15 2001-10-15 Aventis Pharma Gmbh Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

Also Published As

Publication number Publication date
AU3431695A (en) 1996-05-02
BR9504456A (pt) 1997-05-20
NO954139L (no) 1996-04-22
FI954946L (fi) 1996-04-20
IL115641A0 (en) 1996-01-19
JPH08225544A (ja) 1996-09-03
DE4437406A1 (de) 1996-04-25
SI9500329A (en) 1996-04-30
CZ271295A3 (en) 1996-08-14
EP0708093A1 (de) 1996-04-24
NO306615B1 (no) 1999-11-29
PT708093E (pt) 2001-06-29
FI954946A7 (fi) 1996-04-20
ATE198747T1 (de) 2001-02-15
SK128495A3 (en) 1996-06-05
MY132057A (en) 2007-09-28
GR3035673T3 (en) 2001-06-29
HK1011988A1 (en) 1999-07-23
DE59508969D1 (de) 2001-02-22
EP0708093B1 (de) 2001-01-17
AU708293B2 (en) 1999-07-29
NZ280258A (en) 1997-09-22
ZA958783B (en) 1996-05-09
CN1094930C (zh) 2002-11-27
FI954946A0 (fi) 1995-10-17
HU9503005D0 (en) 1995-12-28
PL184860B1 (pl) 2003-01-31
NO954139D0 (no) 1995-10-18
HRP950524A2 (en) 1997-10-31
CA2160859A1 (en) 1996-04-20
DK0708093T3 (da) 2001-04-30
TW328954B (en) 1998-04-01
US5723461A (en) 1998-03-03
ES2154311T3 (es) 2001-04-01
KR960014108A (ko) 1996-05-22
CN1135483A (zh) 1996-11-13
HUT73485A (en) 1996-08-28
PL311016A1 (en) 1996-04-29

Similar Documents

Publication Publication Date Title
HRP950524B1 (en) Quinoxaline, process for its preparation and the use thereof
HU9302696D0 (en) Process for producing aza quinoxaline derivatives and medical preparatives containing these compounds
GR3017651T3 (en) Quinolonecarboxylic acid derivative.
EP0342675A3 (en) Novel quinolonecarboxylic acid derivatives
NZ290389A (en) Substituted pyrimidines typically substituted by -piperazin-1-yl
ES8602754A1 (es) Un procedimiento para la obtencion de agentes antibacteria- nos a base de acidos 7-amino-1-ciclopropil-6,8-difluor-1, 4-dihidro-4-oxo-3-quinolincarboxilicos
ZA918331B (en) Antimicrobial agents as well as substituted 2-cyclohexan-1-yl-amine derivatives and their preparation
AU1485392A (en) Quinoxalines, processes for their preparation, and their use
MX9708696A (es) Cefalosporinas antibacterianas.
IL118368A (en) N-oxide quinoxaline derivatives
DE3682032D1 (de) Propylamine, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
MX9702203A (es) Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
IL117150A (en) Substituted benzenesulfonylureas and - thioureas processes for their preparation their use in the preparation of medicaments and pharmaceutical compositions containing them
ATE189806T1 (de) Substituierte benzylderivate von polyalkylenpolyaminen und ihre verwendung in kosmetischen und pharmazeutischen zusammensetzungen
EP0487996B1 (de) 3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
GR930300124T1 (en) Bile acid sulfurated derivatives
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
MX9705390A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.
IL99369A0 (en) Pharmaceutical compositions containing substituted 2-cyclohexene derivatives
ZA908309B (en) Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives
ES459473A1 (es) Procedimiento para la preparacion de nuevas 9-alcohilamino- eritromicinas.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH, DE

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20021018

Year of fee payment: 8

PBON Lapse due to non-payment of renewal fee

Effective date: 20031019